Tus kws kho mob
P41-17 PCA Agencies Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 17, 2017
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2581 - 2590 ntawm 4205
Tus kws kho mob
P40-17 New Prior Authorization Requirements for Immunomodular Drugs
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 12, 2017
Tus kws kho mob
P20-18 2018 Renewal Changes Summary For Blue Plus Referral Health Professional Providers
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P38-17 New Drug-Related Prior Authorization (PA) for Xolair
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 05, 2017
Tus kws kho mob
P28-18 Change to Administration of Interpreter Services for MHCP Subscribers
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 28, 2018
Tus kws kho mob
2018 July Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 02, 2018
Tus kws kho mob
P62-17 Addition of Drug to the Parathyroid Hormone Analog for Osteoporosis Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 06, 2017
Tus kws kho mob
P22-18 2018 Renewal Changes Summary For Suppliers Of Durable Medical Equipment (DME)
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P67-17 PA Requirements for New Medicare Advantage Prescription Drug Products in 2018
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 06, 2017
Tus kws kho mob
P79-17 Clarification to MHCP PA Requirements for Pelvic Floor Stimulator
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 12, 2017